Cooper Caywood

Karen Caywood / Honor Pages

  • $47,776


  • $40,000


  • 109


Recent Transactions

About Cooper Caywood

On May 7, 2018, we were told our son, Cooper, 14.5 years old, would not be leaving the ICU. EVER. Alive anyway.

It had been over two arduous years throwing all the medical world offered at the monstrous beast of sarcomas, rhabdomyosarcoma. Neither Cooper, nor we, were going to survive this nightmare while on earth.

In the days following, I contacted Dr. Charles Keller at Children's Cancer Therapy Development Institute. I still grasped desperately to hope, was there anything else we could do?

It is an inexplicable experience to be asking and hoping for the miracle while shopping for a coffin for your child on the same day.

Dr. Charles Keller and Andy Woods jumped into action, arranging for pleural fluid to be overnighted to the Portland, OR lab where Andy spent the next 24 hours running any possible toxic combination against the mutating and multiplying cancer cells from Cooper's chest.

Dr. Keller was in constant communication with me and Cooper's oncologist.  What else could be done? Was there anything known to the medical community available to buy us more time? Just a little more time.

The answer 5 years ago was that there was nothing else to stop those vulturous cells from continuing to spread. Excruciatingly, I must tell you that today is the same. Almost 1500* children’s and teen’s families will receive this news, this year, “there is ‘Nothing else’. 

The team at Children's Cancer Therapy Development has been and continues to work and search for more options, any options, considering all options. But there are so many, so many obstacles to saving 1500 children from dying each year.

Dr. Charles Keller and his team at Children’s Cancer Therapy Institute continue to be devoted to finding ways around these obstacles. And we must continue to HOPE.

Your kind and financial support drive the research happening in Hillsboro, OR. 

Thank you for this support. All of Cooper’s honor funds are contributed to The Megan Bugg Global Rhabdomyosarcoma Research Laboratory at the Children’s Cancer Therapy Development Institute.

Facebook Comments